Please provide your email address to receive an email when new articles are posted on . LOUISVILLE, Ky. — Patients with asthma had a greater risk for ischemic heart disease compared with those without ...

In many patients, annual short-acting beta2-agonist prescription fulfillment is indicative of uncontrolled disease and increased incidence of exacerbations. Credit: Getty Images. Short-acting beta ...

The global trial met its primary endpoint showing both doses of rademikibart treatment significantly improved lung function at Week 12 The significant improvement in lung function was observed as ...

The Food and Drug Administration has approved Celltrion’s Omlyclo (omalizumab-igec) as a biosimilar designated as interchangeable with Xolair (omalizumab) for the treatment of moderate to severe ...

High airway TSLP asthma is linked to severe disease, type 2 inflammation, and airway remodelling. Learn more about how TSLP may guide targeted treatment.

(CNN) — The US Food and Drug Administration on Friday approved a medication called Xolair to help lessen the severity of an accidental allergic reaction in people who are allergic to multiple foods.

Dupixent For Moderate-To-Severe Asthma Treatment Market Expected To Reach ~$8.1 Billion By 2032. December 13, 2025 7:27 am - The Dupixent market for moderate-to-severe asthma is valued at $3.25 ...

The FDA approved a new 300 mg/2 mL dose of Celltrion’s omalizumab biosimilar, Omlyclo, for the treatment of four allergic and ...

The ability of four different asthma assessment tools to predict each of five adverse clinical asthma outcomes was modeled using both logistic regression and CART analysis using data collected for non ...

There's been *** rise in childhood food allergies in recent years affecting Children nationwide. These 12 Long Island investigative reporter Rachel Yank Kunis is here now to break down the numbers for ...